Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2005
06/02/2005WO2005050204A1 Method of diagnosing peirodontal disease risk by measuring lactoferrin polypeptide
06/02/2005WO2005050203A2 The methods for screening using ctgf and trka receptor for the identification of compounds for use in treatment of fibrosis
06/02/2005WO2005050202A2 Biological materials and uses thereof
06/02/2005WO2005050201A2 Hairless protein-interacting partner complexes and methods thereof for the beautification and/or improvement of mammalian skin
06/02/2005WO2005050200A2 Screening assays and methods of tumor treatment
06/02/2005WO2005050199A1 Diagnostics and therapeutics for diseases associated with g protein- coupled receptor 77 (gpr77)
06/02/2005WO2005050198A2 Metadherin polypeptides, encoding nucleic acids and methods of use
06/02/2005WO2005050197A2 Diagnostics and therapeutics for diseases associated with protein-coupled inwardly rectifying potassium channel girk4 (girk4)
06/02/2005WO2005050196A1 Method of confirming hydrogen/deuterium exchange in constructions of biological samples and determining the percentage of deuterium in biological samples
06/02/2005WO2005050195A1 Methods relating to molding optical lenses
06/02/2005WO2005050194A1 A device for inspecting and controlling the density of a moving web of cloth in a production line
06/02/2005WO2005050193A1 Gas sensor with controller, and system and method for employing same
06/02/2005WO2005050191A1 Method of simultaneously analyzing oxidatively injured guanine compound and substance correcting the concentration thereof and analzyer to be used in the analysis method
06/02/2005WO2005050189A1 Device and method for the detection of defects in reinforcements of concrete components
06/02/2005WO2005050188A1 Quantification method with the use of isotope-labeled internal standard, analysis system for carrying out the quantification method and program for dismantling the same
06/02/2005WO2005050182A1 Resonance energy transfer assay system for multi-component detection
06/02/2005WO2005050173A1 Device for removing volatile organic carbon compounds from a process liquid
06/02/2005WO2005050171A2 Methods and compositions relating to single reactive center reagents
06/02/2005WO2005050170A2 Methods and compositions for inhibiting intracellular aggregate formation
06/02/2005WO2005050169A2 Sample collection cup with integrated activatable sample analysis system
06/02/2005WO2005050167A2 Rapid sample collection and analysis device
06/02/2005WO2005050166A2 Fluid sample analysis device with sealable sample storage reservoir
06/02/2005WO2005050165A2 Rapid sample analysis and storage devices and methods of use
06/02/2005WO2005050164A2 Detection systems and methods
06/02/2005WO2005050157A2 Electrochemical method and sensor for the detection of trace explosives
06/02/2005WO2005050155A2 Parallel reactor
06/02/2005WO2005049867A1 Methods for identifying modulators of quadruplex nucleic acids
06/02/2005WO2005049862A2 Method for analysis by molecular hybridation of nucleic acids and kit for carrying out said method
06/02/2005WO2005049858A1 Method of determining substrate contained in hemoglobin-containing sample
06/02/2005WO2005049857A1 Method of assyaing glycoprotein
06/02/2005WO2005049856A2 Methods and apparatus for the rapid detection of microorganisms collected from infected sites
06/02/2005WO2005049855A1 Method of determining ligand
06/02/2005WO2005049838A2 Syk-targeted nucleic acid interference
06/02/2005WO2005049833A1 Gene encoding g protein-coupled receptor and gene product thereof
06/02/2005WO2005049832A2 FcϜRIIA-SPECIFIC NUCLEIC ACID INTERFERENCE
06/02/2005WO2005049826A1 Method of detecting target molecule by using aptamer
06/02/2005WO2005049825A1 Method of detecting signal transduction by g protein-coupled receptor using germination baculovirus
06/02/2005WO2005049814A2 Novel atypical pneumonia-causing virus
06/02/2005WO2005049809A1 Inhibition assay method and device for detection of antibiotics
06/02/2005WO2005049804A2 Engineering enzymes through genetic selection
06/02/2005WO2005049802A2 Anti-hydroxylase antibodies and uses thereof
06/02/2005WO2005049799A2 Chimeric chemokine receptor polypeptides
06/02/2005WO2005049794A2 Methods of characterizing infectious bursal disease virus
06/02/2005WO2005049790A2 Skn-1 and gsk-3 genes and proteins
06/02/2005WO2005049789A2 Synthetic mammalian retrotransposon gene
06/02/2005WO2005049786A2 Modulation of angiogenesis by bartonella henselae
06/02/2005WO2005049741A1 Formation of self-assembled monolayers
06/02/2005WO2005049655A1 Leptin antagonist and method for quantitative measurement of leptin
06/02/2005WO2005049654A1 ANTI-Kank MONOCLONAL ANTIBODY
06/02/2005WO2005049651A2 Cancer diagnosis and therapy
06/02/2005WO2005049636A2 Method of analyzing protein
06/02/2005WO2005049590A2 N-sulfonylaminocarbonyl containing compounds
06/02/2005WO2005049579A2 Immobilized n-substituted tricyclic 3-aminopyrazoles for the identification of biomolecular targets
06/02/2005WO2005049084A2 Inhibition of trp channels as a treatment for cardiac hypertrophy and heart failure
06/02/2005WO2005049073A2 Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients
06/02/2005WO2005049066A2 Use of dudulin2 for the treatment or prophylaxis of lung cancer
06/02/2005WO2005049063A2 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
06/02/2005WO2005048936A2 Modulators of dimethylarginine dimethylaminohydrolase and methods of use thereof
06/02/2005WO2005048913A2 Mutant lrp5/6 wnt-signaling receptors in cancer diagnosis, prognosis and treatment
06/02/2005WO2005048834A1 Long term analyte sensor array
06/02/2005WO2005048823A2 Modeling of systemic inflammatory response to infection
06/02/2005WO2005048807A2 Diagnosis of a type ii tumor within a mullerian-derived site by detection of glial fibrillary acidic proteic (gfap)
06/02/2005WO2005033711A3 Clot lysis assay
06/02/2005WO2005033158A3 Attachment of molecules to surfaces
06/02/2005WO2005031349A3 Label-free methods for performing assays using a colorimetric resonant reflectance optical biosensor
06/02/2005WO2005031325B1 Method and device for the detection of very small quantities of particles
06/02/2005WO2005031304A3 Quantification of analytes using internal standards
06/02/2005WO2005030241A3 Treating inflammation using a biological agent that causes cells to release cytokine receptors
06/02/2005WO2005029089A3 Method of diagnosing ovarian endometriosis using tfpi-2 protein
06/02/2005WO2005029039A3 Non-radioactive inositol phosphate assay for phospholipase c-coupled drug target screening
06/02/2005WO2005028675A3 Methods for detecting, diagnosing and treating hepatocellular carcinomas (hcc)
06/02/2005WO2005026681A3 Magnetostrictive ligand sensor devices and uses thereof
06/02/2005WO2005026393A3 Biological particulate matter analogue
06/02/2005WO2005025497A3 Hpv cd8+ t-cell epitopes
06/02/2005WO2005019818A3 Support element for use in the analysis of substances
06/02/2005WO2005019526A3 System and method for controlling a processor including a digester utilizing time-based assessments
06/02/2005WO2005018413A3 Methods, kits and antibodies for detecting parathyroid hormone
06/02/2005WO2005016122A3 Npas3 mutant mice and uses for screening and testing therapies for schizophrenia and related neurological disorders
06/02/2005WO2005015190A9 Method and arrangement for detecting substances by means of regulation of an electrical resistance of a sensor
06/02/2005WO2005013889A9 Truncated fragments of alpha-synuclein in lewy body disease
06/02/2005WO2005011728A3 Use of soluble cd164 in inflammatory and/or autoimmune disorders
06/02/2005WO2005010026A3 Methods for detecting activation of t-cells by mhc binding peptides
06/02/2005WO2005009224A3 Methods and compositions for evaluation and modulations of fertility
06/02/2005WO2004113922A3 System and method employing photokinetic techniques in cell biology imaging applications
06/02/2005WO2004112572A3 Monitoring immunologic, hematologic and inflammatory diseases
06/02/2005WO2004111648A3 Plasma polymerisation methods for the deposition of chemical gradients and surfaces displaying a gradient of immobilised biomolecules
06/02/2005WO2004110384A3 Hiv-1 envelope glycoproteins having unusual disulfide structure
06/02/2005WO2004104577A3 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 4 (5-ht4)
06/02/2005WO2004099781A3 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor rdc1 (rdc1)
06/02/2005WO2004096984A3 Preservation of rna in a biological sample
06/02/2005WO2004093784A3 Systems and methods for blood glucose sensing
06/02/2005WO2004092728A3 Methods of measuring the ability of a test compound to inactivate a biological target in cells of a subject
06/02/2005WO2004092384A3 Means and methods for diagnosing and treating affective disorders
06/02/2005WO2004090506A3 Surfaces that selectively bind to moieties
06/02/2005WO2004088324A3 Proteomic analysis of biological fluids
06/02/2005WO2004088309A3 Methods for diagnosing urinary tract and prostatic disorders
06/02/2005WO2004081025A3 Differential megaplex immunoassay
06/02/2005WO2004076648A3 Clinically relevant animal model of human breast cancer and vegf involement in desmoplastic response.
06/02/2005WO2004075812A3 Diagnostics and therapeutics for diseases associated with phosphodiesterase 3b (pde3b)
06/02/2005WO2004074320A3 Therapeutic targets in cancer
1 ... 2106 2107 2108 2109 2110 2111 2112 2113 2114 2115 2116 2117 2118 2119 2120 2121 2122 2123 2124 2125 2126 ... 3937